Related Experiment Video
Updated: Aug 11, 2025
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
MRI-visible mesoporous polydopamine nanoparticles with enhanced antioxidant capacity for osteoarthritis therapy
Sitong Liu1, Chen Zhang1, Yuanyuan Zhou1
1School of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, China.
Abstract:
Since the progression of osteoarthritis (OA) is closely associated with synovitis and cartilage destruction, the inhibition of inflammatory responses in synovial macrophages and reactive oxygen species (ROS) induced apoptosis in chondrocytes is crucial for OA amelioration. However, most of the current anti-inflammatory and antioxidant drugs are small molecules apt to be eliminated in vivo. Herein, mesoporous polydopamine nanoparticles (DAMM NPs) doped with arginine and manganese (Mn) ions were prepared to load dexamethasone (DEX) for OA intervention. A series of in vitro studies showed that the sustained release of DEX from DAMM NPs suppressed synovial inflammation and simultaneously inhibited toll-like receptor 3 (TLR-3) production in chondrocytes, contributing to prevention of chondrocyte apoptosis through the inflammatory factor-dependent TLR-3/NF-κB signaling pathway via modulation of macrophage-chondrocyte crosstalk. In addition, DAMM NPs exerted a predominant role in removal of ROS generated in chondrocytes. Therefore, the DEX-loaded DAMM NPs significantly attenuated OA development in mice model. Importantly, the T1-T2 magnetic contrast capabilities of DAMM NPs allowed an MRI-trackable delivery, manifesting a distinct feature widely regarded to boost the potential of nanomedicines for clinical applications. Together, our developed antioxidant-enhanced DAMM NPs with MRI-visible signals may serve as a novel multifunctional nanocarriers for prevention of OA progression.
Insights
Novel nanoparticles loaded with dexamethasone effectively treat osteoarthritis by reducing inflammation and oxidative stress. These MRI-trackable nanocarriers offer a promising new approach for osteoarthritis intervention and clinical applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Osteoarthritis Research
Background:
- Osteoarthritis (OA) progression involves synovitis and cartilage destruction, driven by inflammatory responses and oxidative stress.
- Current treatments using small molecule drugs face limitations due to rapid in vivo elimination.
- Targeting macrophage-chondrocyte crosstalk and reactive oxygen species (ROS) is crucial for OA amelioration.
Purpose of the Study:
- To develop and evaluate mesoporous polydopamine nanoparticles (DAMM NPs) loaded with dexamethasone (DEX) for osteoarthritis intervention.
- To investigate the anti-inflammatory and antioxidant properties of DEX-loaded DAMM NPs.
- To assess the potential of these nanoparticles for MRI-trackable delivery and clinical application.
Main Methods:
- Preparation of mesoporous polydopamine nanoparticles (DAMM NPs) doped with arginine and manganese (Mn) ions, loaded with dexamethasone (DEX).
- In vitro assessment of DEX sustained release, suppression of synovial inflammation, and inhibition of toll-like receptor 3 (TLR-3) production in chondrocytes.
- Evaluation of ROS removal capacity and chondrocyte apoptosis prevention via the TLR-3/NF-κB signaling pathway.
- In vivo study using a mouse model of osteoarthritis and MRI tracking of nanoparticle delivery.
Main Results:
- Sustained DEX release from DAMM NPs effectively suppressed synovial inflammation and TLR-3 production in chondrocytes.
- The nanoparticles modulated macrophage-chondrocyte crosstalk, preventing chondrocyte apoptosis through the TLR-3/NF-κB pathway.
- DAMM NPs demonstrated significant ROS scavenging activity and attenuated OA development in a mouse model.
- The T1-T2 magnetic contrast properties enabled MRI-trackable delivery, highlighting clinical potential.
Conclusions:
- DEX-loaded DAMM NPs represent a multifunctional nanocarrier for osteoarthritis intervention, combining anti-inflammatory and antioxidant effects.
- The developed nanoparticles effectively inhibit OA progression by targeting key molecular pathways and reducing oxidative stress.
- The MRI-visible signals and trackable delivery enhance the translational potential of these nanomedicines for clinical applications in OA treatment.
